Shanghai World Pharmaceutical Contract Customization Service Exhibition (ICSE China) integrates global pharmaceutical industry resources to help Chinese enterprises achieve rapid development. Hosted by Informa Markets, the exhibition currently covers almost all stages of new drug R&D in the contract outsourcing service sector of the pharmaceutical industry, becoming an indispensable part of the pharmaceutical R&D industrial chain. The emerging CRO & CMO market represented by the Asia-Pacific region is currently experiencing rapid growth, with a growth rate far exceeding the global average.

Shanghai World Pharmaceutical Contract Customization Service Exhibition (ICSE China) is the first theme exhibition for the domestic pharmaceutical industry focusing on CRO & CMO. It gathers high-quality domestic and international CRO & CMO companies, showcasing advanced products and technologies in the fields of pharmaceutical R&D and outsourcing services. The audience mainly comes from countries and regions such as Japan, South Korea, North America, Europe, India, and Southeast Asia, including senior management and procurement directors of well-known biopharmaceutical companies worldwide such as Roche, Merck, Amgen, Eli Lilly, Bayer, Johnson & Johnson, Sanofi, Novartis, AstraZeneca, etc.

At the Shanghai World Pharmaceutical Contract Customization Service Exhibition ICSE China, many renowned exhibitors will exchange advanced products and technologies in the field of pharmaceutical R&D and production outsourcing services, and jointly explore various changes in the future industry. It builds an information exchange platform that integrates trade, social networking, and knowledge acquisition for professionals in the industry.